Feed GLAXF
GL

GSK plc GLAXF OTC · Healthcare · United Kingdom

$23.40 -4.29% -$1.05

Market cap
£71.7B
Enterprise value
£92.6B
P/E
16.6x
Forward P/E
9.7x
PEG
0.1x
P/S
2.1x
P/FCF
10.6x
EV/EBITDA
8.8x
ROIC
10.5%
Gross margin
73.6%
Net margin
12.9%
Dividend yield
3.95%
Payout ratio
65.5%
Net debt/EBITDA
2.0x
Beta
0.30
Free float
97.0%

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Luke Victor Miels

Employees

66,841

Headquarters

London

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Earnings per share fell by 28% a year over the last 3 years.
  • What to watch: Earnings per share swing sharply from year to year.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 GBP of revenue, 13 GBP is left as net profit.

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy